Home > Courses > Controversies in Testosterone Treatment 2020 in Cisgender and Transgender Men

Controversies in Testosterone Treatment 2020 in Cisgender and Transgender Men

Sorry, this learning module is not available for mobile devices.

Watch this Learning Module

COLLABORATION STATEMENT: The AIDS Institute is proud of the ongoing collaboration between the Clinical Education Initiative (CEI) and Physicians Research Network (PRN). Founded in 1990, PRN has a well-established reputation for spotlighting the work of the most innovative and influential leaders in the HIV treatment, prevention and research fields through its monthly meetings in New York City. Since 2010, CEI has featured recordings of PRN's monthly events through the CEI website. The combined efforts of both educational institutions have enhanced the continuing educational resources available to New York State clinicians caring for people living with, or at risk for HIV.

Original Release Date: 11/11/2020

Termination Date: 11/10/2023

Review Date: 4/19/2021

Learning Objectives / Desired Outcomes

At the completion of this educational activity, participants will:

Understand the potential risks and benefits of testosterone treatment in the older cisgender male.
Be familiar with the findings of the T Trials and the clinical questions that still remain.
Understand what is known about the risks of testosterone for gender-affirming therapy in transgender men.

Presenter

Todd T. Brown, MD, PhD
Associate Professor of Medicine
Johns Hopkins University

Presenter Bio

Dr. Brown is a Professor of Medicine and Epidemiology in the Division of Endocrinology, Diabetes, and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. He is a graduate of Columbia University College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, as related to aging. Dr. Brown is particularly interested in the aging-related outcomes of cardiovascular disease, fractures, and frailty in persons living with HIV. He is a co-investigator in the Multicenter AIDS Cohort Study and the AIDS Clinical Trial Group. In the MACS, he is the co-Principal Investigator of the Baltimore/Washington DC site and is the former chair of the Metabolic Working Group. In the ACTG, he has served in leadership positions on multiple observational and interventional studies, including a substudy of REPRIEVE, the large statin trial in low CVD risk, persons living with HIV. He is a member of the Organizing Committee of the International Workshop on Comorbidities and Adverse Drug Reactions in HIV, now in its 20th year. He has published over 170 articles and book chapters on endocrine and metabolic problems and their consequences in HIV-infected persons and has lectured internationally on these topics.

Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on November 11, 2020 and will terminate November 10, 2023.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.

Dr. James Braun (Planner/Course Director) has no relevant financial relationships to disclose.
Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose
Dr. Todd Brown (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Gilead, Janssen, Merck, Theatechnologies, and ViiV. Dr. Brown will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details:

This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

PRN Learning Modules